UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 19, 2020 4:00 P.M.

Form:	S-3
CIK: 0001626971 Company Name: Corvus Pharmaceuticals, Inc. File Number: 333-237040